Literature DB >> 17114151

The use of flupirtine in treatment of tinnitus.

L Salembier1, D De Ridder, P H Van de Heyning.   

Abstract

CONCLUSION: Flupirtine, a functional NMDA antagonist, does not seem to be efficacious in the treatment of tinnitus.
OBJECTIVES: The purpose of this study was to investigate whether flupirtine has any beneficial effect on tinnitus perception. PATIENTS AND METHODS: Twenty-four patients were selected (6 female and 18 male patients) with continuous subjective tinnitus. Eight patients suffered left-sided tinnitus, 4 right-sided tinnitus and 12 bilateral tinnitus. We assessed the burden of the tinnitus by loudness visual analogue scale (VAS) and tinnitus questionnaire (TQ) according to Hallam et al., and Hiller and Goebel. All patients were treated with a 2 x 100 mg daily dosage of oral flupirtine for 3 weeks in an open prospective design.
RESULTS: There was no statistical effect on VAS and TQ of the treatment with flupirtine. Only one patient (4.2%) experienced a positive effect on the tinnitus but discontinued the treatment because of amnesia and concentration disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114151     DOI: 10.1080/03655230600895242

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  8 in total

1.  Unexpected frequent hepatotoxicity of a prescription drug, flupirtine, marketed for about 30 years.

Authors:  Martin C Michel; Piotr Radziszewski; Christian Falconer; Daniela Marschall-Kehrel; Koenraad Blot
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

Review 2.  Emerging pharmacotherapy of tinnitus.

Authors:  Berthold Langguth; Richard Salvi; Ana Belén Elgoyhen
Journal:  Expert Opin Emerg Drugs       Date:  2009-12       Impact factor: 4.191

3.  Evidence of key tinnitus-related brain regions documented by a unique combination of manganese-enhanced MRI and acoustic startle reflex testing.

Authors:  Avril Genene Holt; David Bissig; Najab Mirza; Gary Rajah; Bruce Berkowitz
Journal:  PLoS One       Date:  2010-12-15       Impact factor: 3.240

Review 4.  The Management and Outcomes of Pharmacological Treatments for Tinnitus.

Authors:  Devon Beebe Palumbo; Kathleen Joos; Dirk De Ridder; Sven Vanneste
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

5.  Randomized controlled trial about pain medication flupirtine ignores recent pharmacovigilance warnings.

Authors:  Livia Puljak
Journal:  J Pain Res       Date:  2018-01-12       Impact factor: 3.133

Review 6.  A Review on Peripheral Tinnitus, Causes, and Treatments from the Perspective of Autophagy.

Authors:  Karthikeyan A Vijayakumar; Gwang-Won Cho; Nagarajan Maharajan; Chul Ho Jang
Journal:  Exp Neurobiol       Date:  2022-08-31       Impact factor: 3.800

7.  Efficacy and safety of bilateral continuous theta burst stimulation (cTBS) for the treatment of chronic tinnitus: design of a three-armed randomized controlled trial.

Authors:  Carola Arfeller; Reinhard Vonthein; Stefan K Plontke; Christian Plewnia
Journal:  Trials       Date:  2009-08-21       Impact factor: 2.279

8.  Local NMDA receptor blockade attenuates chronic tinnitus and associated brain activity in an animal model.

Authors:  Thomas J Brozoski; Kurt W Wisner; Boris Odintsov; Carol A Bauer
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.